| 6th Jun 2023 7:00 am |
RNS |
Notice of Annual General Meeting |
| 5th Jun 2023 7:00 am |
RNS |
Annual Report & Financial Statements - 31 Dec 2022 |
| 2nd May 2023 7:56 am |
RNS |
Suspension of Trading Pending 2022 Annual Report |
| 2nd May 2023 7:30 am |
RNS |
Suspension - Roquefort Therapeutics plc |
| 13th Mar 2023 7:30 am |
RNS |
Confirmation of No Exposure to Silicon Valley Bank |
| 8th Mar 2023 7:00 am |
RNS |
Creation of New Novel Family of mRNA Therapeutics |
| 6th Mar 2023 7:00 am |
RNS |
Formation of Scientific Advisory Board |
| 1st Mar 2023 7:00 am |
RNS |
Company Presentation |
| 21st Feb 2023 7:00 am |
RNS |
Investor Presentation |
| 20th Feb 2023 7:00 am |
RNS |
Randox Licence and Royalty Agreement |
| 24th Jan 2023 7:00 am |
RNS |
MDK Oncology Antibodies Demonstrate In-Vivo Safety |
| 18th Jan 2023 8:36 am |
RNS |
Holding(s) in Company |
| 16th Jan 2023 7:00 am |
RNS |
Appointment of Auditor |
| 9th Jan 2023 7:00 am |
RNS |
Operations Update |
| 5th Dec 2022 8:07 am |
RNS |
Presentation of Midkine Oligonucleotide Program |
| 1st Dec 2022 2:00 pm |
RNS |
Resignation of Auditor |
| 25th Oct 2022 7:00 am |
RNS |
Midkine Antibody Program - Festival of Biologics |
| 11th Oct 2022 7:00 am |
RNS |
ROQ Presents Study Results at the ESGCT Conference |
| 28th Sep 2022 7:00 am |
RNS |
Director/PDMR Shareholding |
| 26th Sep 2022 2:30 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Sep 2022 7:00 am |
RNS |
Interim Results to 30 June 2022 |
| 23rd Sep 2022 7:00 am |
RNS |
Interim Results to 30 June 2022 |
| 16th Sep 2022 8:00 am |
RNS |
Investor Presentation |
| 16th Sep 2022 7:01 am |
RNS |
Board and Management Appointments |
| 16th Sep 2022 7:00 am |
RNS |
Acquisition Completion, Admission & Voting Rights |
| 15th Sep 2022 12:26 pm |
RNS |
Notice of Admission |
| 13th Sep 2022 11:08 am |
RNS |
Publication of Prospectus |
| 11th Aug 2022 7:00 am |
RNS |
Pre-clinical Program & Transaction Update |
| 20th Jul 2022 7:00 am |
RNS |
Appointment of Joint Broker |
| 15th Jul 2022 7:00 am |
RNS |
Commencement of Trading on US OTCQB Venture Market |
| 4th Jul 2022 4:57 pm |
RNS |
Director/PDMR Shareholding |
| 30th Jun 2022 4:38 pm |
RNS |
Director/PDMR Shareholding |
| 30th Jun 2022 10:30 am |
RNS |
Result of AGM |
| 23rd Jun 2022 7:00 am |
RNS |
Update on Acquisition of Oncogeni and Placing |
| 22nd Jun 2022 4:42 pm |
RNS |
Issue of Warrants |
| 22nd Jun 2022 10:32 am |
RNS |
Investor Presentation |
| 22nd Jun 2022 9:05 am |
RNS |
Second Price Monitoring Extn |
| 22nd Jun 2022 9:00 am |
RNS |
Price Monitoring Extension |
| 22nd Jun 2022 7:00 am |
RNS |
Proposed Acquisition of Oncogeni Limited & Placing |
| 13th Jun 2022 7:00 am |
RNS |
Notice of AGM - Correction |
